TY - JOUR
T1 - The interactions between DNA nanostructures and cells
T2 - A critical overview from a cell biology perspective
AU - Frtús, Adam
AU - Smolková, Barbora
AU - Uzhytchak, Mariia
AU - Lunova, Mariia
AU - Jirsa, Milan
AU - Henry, Skylar J.W.
AU - Dejneka, Alexandr
AU - Stephanopoulos, Nicholas
AU - Lunov, Oleg
N1 - Funding Information:
This research was funded by Operational Programme Research, Development and Education financed by European Structural and Investment Funds and the Czech Ministry of Education, Youth and Sports (Project No. SOLID21 - CZ.02.1.01/0.0/0.0/16_019/0000760) and MH CZ - DRO Institute for Clinical and Experimental Medicine – IKEM, IN 00023001. Nicholas Stephanopoulos acknowledges support from the National Science Foundation (DMR-BMAT CAREER award 1,753,387). Research reported in this publication was supported by The National Institute of General Medical Sciences of the National Institutes of Health under grant number DP2GM132931. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
Publisher Copyright:
© 2022
PY - 2022/7/1
Y1 - 2022/7/1
N2 - DNA nanotechnology has yielded remarkable advances in composite materials with diverse applications in biomedicine. The specificity and predictability of building 3D structures at the nanometer scale make DNA nanotechnology a promising tool for uses in biosensing, drug delivery, cell modulation, and bioimaging. However, for successful translation of DNA nanostructures to real-world applications, it is crucial to understand how they interact with living cells, and the consequences of such interactions. In this review, we summarize the current state of knowledge on the interactions of DNA nanostructures with cells. We identify key challenges, from a cell biology perspective, that influence progress towards the clinical translation of DNA nanostructures. We close by providing an outlook on what questions must be addressed to accelerate the clinical translation of DNA nanostructures. Statement of significance: Self-assembled DNA nanostructures (DNs) offers unique opportunities to overcome persistent challenges in the nanobiotechnology field. However, the interactions between engineered DNs and living cells are still not well defined. Critical systematization of current cellular models and biological responses triggered by DNs is a crucial foundation for the successful clinical translation of DNA nanostructures. Moreover, such an analysis will identify the pitfalls and challenges that are present in the field, and provide a basis for overcoming those challenges.
AB - DNA nanotechnology has yielded remarkable advances in composite materials with diverse applications in biomedicine. The specificity and predictability of building 3D structures at the nanometer scale make DNA nanotechnology a promising tool for uses in biosensing, drug delivery, cell modulation, and bioimaging. However, for successful translation of DNA nanostructures to real-world applications, it is crucial to understand how they interact with living cells, and the consequences of such interactions. In this review, we summarize the current state of knowledge on the interactions of DNA nanostructures with cells. We identify key challenges, from a cell biology perspective, that influence progress towards the clinical translation of DNA nanostructures. We close by providing an outlook on what questions must be addressed to accelerate the clinical translation of DNA nanostructures. Statement of significance: Self-assembled DNA nanostructures (DNs) offers unique opportunities to overcome persistent challenges in the nanobiotechnology field. However, the interactions between engineered DNs and living cells are still not well defined. Critical systematization of current cellular models and biological responses triggered by DNs is a crucial foundation for the successful clinical translation of DNA nanostructures. Moreover, such an analysis will identify the pitfalls and challenges that are present in the field, and provide a basis for overcoming those challenges.
KW - Bionano interactions
KW - Cellular uptake
KW - Cytotoxicity
KW - DNA nanotechnology
KW - Nanotechnology
KW - Protein corona
UR - http://www.scopus.com/inward/record.url?scp=85131652182&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131652182&partnerID=8YFLogxK
U2 - 10.1016/j.actbio.2022.04.046
DO - 10.1016/j.actbio.2022.04.046
M3 - Review article
C2 - 35523414
AN - SCOPUS:85131652182
SN - 1742-7061
VL - 146
SP - 10
EP - 22
JO - Acta Biomaterialia
JF - Acta Biomaterialia
ER -